SHS Gesellschaft für Beteiligungsmanagement mbH

News Current page: 15

Current news of SHS and our portfolio companies

11. March 2021 - Press Releases

Speaking like an Investor – SHS Partner Dr. André Zimmermann in conversation with EIT Health

In a Podcast Caroline Sai of EIT Health and our Partner Andre Zimmermann are discussing in which ways the new MDR is heavily affecting the whole European Medtech area – from start-ups to established medium-sized companies. In addition, SHS is out-lining in which way medium-sized companies and investors can team-up not only to overcome the economical challenges of the MDR for Medtechs but to prosper.

Read more
11. March 2021 - SHS News

Healthcare investor SHS sells stake in Crystal Laser Systems GmbH, a leading manufacturer of deep-UV laser systems for the healthcare, biotech and semiconductor industries

Tübingen-based healthcare investor SHS has provided capital and expertise to Crystal Laser Systems GmbH (CryLaS) on its way to becoming a leading, profitable provider of laser technology and is handing over the baton to Silver Investment Partners SIP CryLaS enjoys an excellent reputation worldwide in the healthcare, biotech and semiconductor sectors with pulsed and CW […]

Read more
4. February 2021 - Newsletter

Regulatory approval for the highly sensitive, high-speed coronavirus test system by GNA Biosolutions

Coming up with reliable figures for the process of infection with the coronavirus requires tests that are dependable and, above all, quick. With the Octea SARS-CoV-2 system, GNA Biosolutions has developed a molecular, highly sensitive test method that delivers a test result with 96.7 percent accuracy in decentralized laboratories in approximately 40 minutes’ time. Octea […]

Read more
4. February 2021 - Newsletter

SHS invests in innovative specialist for drugs formulated specifically for delayed-release effects

Develco Pharma, a Swiss-German firm, has been developing and producing orally administered, delayed-release drugs with special formulations since 2006. Since 2016, the company has produced these drugs in a state-of-the-art production facility located in Schopfheim, in the Baden region of Germany. The dynamic, medium-sized company is gradually growing its pipeline for new drugs, and there […]

Read more
First Previous
...
1314
15
1617
...
Next Last